Navigation Links
FDA Panel Rejects Avastin for Breast Cancer
Date:6/30/2011

ized on Tuesday. Genentech officials also defended E2100, the original study that formed the basis for the FDA's accelerated approval, and said there were no better treatments available for many women, CNN reported.

Lichtenfeld, at the end of the first day of hearings, outlined the dilemma. "Clearly, we are in a place where emotion meets science and the FDA's decision will prove to be a difficult one," he said in his blog.

The advisory panel's vote is non-binding, and FDA commissioner Margaret Hamburg will make a final ruling, the Associated Press reported.

The FDA's unusual step of scheduling another hearing on the drug underscored the difficulty of withdrawing approval of a cancer medication, the AP reported.

"It says to me that either they [the FDA] have gotten a great deal of negative feedback from various quarters, or there's some kind of internal disagreement within the agency," Dr. Gary Lyman, professor at the Duke Cancer Institute in North Carolina, told the news service. Lyman was part of the FDA advisory panel that voted 12-1 last year to revoke Avastin's approval as a breast cancer therapy.

The FDA's December recommendation did not immediately affect breast cancer patients' access to the drug or limit use of Avastin (bevacizumab) for advanced colon, lung, kidney and brain cancer.

Doctors can continue to prescribe Avastin to patients "off-label," as they do other drugs. But it's unlikely that insurance companies would cover off-label use of the drug given its high price tag. Avastin costs more than $8,000 a month, according to published reports.

Avastin was OK'd in 2008 for use in metastatic breast cancer in conjunction with chemotherapy under the FDA's accelerated approval program. Approval was based on a clinical trial of patients with metastatic HER2-negative breast cancer that found a benefit in terms of cancer recurrence -- but not overall survival -- and was contingent on further dat
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
2. FDA Panel Delays Action on Dyes Used in Foods
3. FDA Panel Examines Possible Links Between Food Dyes, ADHD
4. FDA Panel: Ban on Menthol Cigarettes Would Boost Health
5. Menthol Cigarettes Marketed as Healthier, FDA Panel Says
6. International panel revises McDonald Criteria for diagnosing multiple sclerosis
7. FDA Panel Recommends Testing of Electroshock Devices
8. FDA Panel Recommends Tougher Standards for External Defibrillators
9. AADR testifies to the FDA advisory panel on dental amalgam
10. FDA Panel Calls for Safety Review of Mercury in Dental Fillings
11. New Diet Pill Wins FDA Panels Backing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Rejects Avastin  for Breast Cancer 
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer ... sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and ... highly respected and well established national certification organization for renewable energy professionals. Designation ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief nursing ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... ... , ... Jennifer Renee Hanes, DO is the new Medical Director of its ... independent freestanding emergency rooms in the United States. , “We are excited to welcome ... Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and ... they provide members of the Red Deer community with free fitness training and indoor ... training, games, food, events and entertainment raised thousands of charity dollars and ended with ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... Available Digitally on iTunes June 10th and In-Stores July 1st ... runaway hit overseas, Chant,- Music For The Soul debuted at ... bested the likes of Amy Winehouse and Leona Lewis. Not,surprising ... is a,much-needed growing phenomenon, featuring traditional chant from the 12th,and ...
... DIEGO and MCLEAN, Va., June 10 SAIC, Inc.,(NYSE: ... Blair Annual,Growth Stock Conference in Chicago on June 18, 2008. ... 3:10 p.m. Central., A live audio webcast of the ... ( http://investors.saic.com ) and an audio,replay of the event will ...
... PITTSBURGH, June 10 Mylan Inc. (NYSE: MYL ... the Federal Circuit has,affirmed a May 2007 District Court ... delayed-release capsules do not infringe patents asserted,against Mylan by ... Mylan launched its Omeprazole products on August 4, ...
... perform, yields instant result, study says , , TUESDAY, June ... have a longer than normal QRS duration (a measurement ... an electrocardiogram) appear to have a high risk of ... data from 2,962 patients hospitalized for heart failure who ...
... popularity of golf carts has skyrocketed in recent years, ... injuries. In fact, a new study conducted by researchers ... The Research Institute at Nationwide Children,s Hospital found that ... during the 17-year study period. , According to ...
... Selective,Insurance Group, Inc. (Nasdaq: SIGI ) announced ... of America ("Selective"):, Fred J. Ferraro (New ... manager. Previously he served as vice president and ... 2003 as a senior,equity research analyst. Prior to ...
Cached Medicine News:Health News:Live a Longer and More Peaceful Life With Chant - Music For The Soul 2Health News:SAIC to Webcast Presentation at William Blair Growth Stock Conference 2Health News:ECG Reading May Predict Death, Rehospitalization Risk 2Health News:First national study to examine golf cart-related injuries 2Health News:Selective Insurance Group Announces Officer Appointments 2Health News:Selective Insurance Group Announces Officer Appointments 3
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 /PRNewswire/ ... acquisition of assets related to the ion channel biology ... had previously been obtained as part of Pfizer,s 2011 ... of Pfizer,s rights to the "Icagen" name and trademark. ... provide comprehensive services for ion channel and transporter drug ...
(Date:7/2/2015)... Research and ... of the "2015 New Frontiers in ... Technologies, Competitive Landscape" report to their ... Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging ... strategic analysis of major business opportunities emerging ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... Therapeutics, Inc. (OTC Bulletin Board: ECTE ), ... a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system ... today announced results for the year ended December 31, ... through Echo,s website at www.echotx.com . ...
... March 21, 2011 CardioFocus , a venture ... disorders, has secured $5M in debt financing from ... life science companies of all sizes worldwide. CardioFocus will ... in the United States and to expand the commercialization ...
Cached Medicine Technology:Echo Therapeutics Announces 2010 Financial Results 2Echo Therapeutics Announces 2010 Financial Results 3Echo Therapeutics Announces 2010 Financial Results 4CardioFocus Secures $5M Credit Facility with Silicon Valley Bank 2